Pharmacology, Toxicology and Pharmaceutical Science
Malignant Neoplasm
100%
Colorectal Cancer
55%
Anticarcinogen
51%
Tumor Growth
47%
Histone Deacetylase Inhibitor
44%
Histone Deacetylase 6
44%
Neoplasm
43%
IC50
41%
Prostate Cancer
40%
Antitumor Activity
40%
Tubulin
38%
Phosphotransferase
38%
Non Small Cell Lung Cancer
31%
Histone Deacetylase
27%
Liver Cell Carcinoma
25%
Pancreas Cancer
24%
Calcium Ion
24%
Vorinostat
24%
Cytotoxicity
23%
Caspase 3
23%
Antiproliferative Activity
22%
Mitogen Activated Protein Kinase
21%
Phosphatidylinositide
21%
Western Blot
20%
Cancer Growth
20%
Lung Cancer
19%
Bradykinin
18%
Mouse
18%
Disease
16%
Breast Cancer
16%
Restenosis
16%
Caspase
15%
Antiangiogenic
15%
Hydroxamic Acid
15%
Virtual Screening
14%
Indazole Derivative
14%
Acute Myeloid Leukemia
14%
Protein Kinase C
13%
Protein P53
13%
Lificiguat
13%
Renal Cell Carcinoma
13%
Epidermal Growth Factor Receptor
13%
Inositol Phosphate
13%
STAT3 Protein
12%
Structure Activity Relationship
12%
Vasculotropin
12%
Hypoxia Inducible Factor 1
12%
Mitogen Activated Protein Kinase 3
11%
Mouse Model
11%
Nuclear Factor
11%
Biochemistry, Genetics and Molecular Biology
Cancer Cell
63%
Anticancer
29%
Signal Transduction
23%
Phosphotransferase
21%
Kinase
21%
Angiogenesis
20%
Histone Deacetylase
19%
Caspase
18%
IC50
17%
HDAC6
16%
Tumor Progression
16%
Tubulin
15%
Antineoplastic Activity
14%
Cell Death
14%
Mitosis Inhibition
13%
Cytotoxicity
12%
Cell Cycle
12%
Tau
11%
Microtubule Assembly
11%
Dynamics
11%
Hypoxia Inducible Factor 1
10%
Integrin-Linked Kinase
10%
Tyrosine Phosphorylation
10%
Caspase 3
10%
Cell Growth
9%
Cell Proliferation
9%
Mitochondrion
9%
Mitochondrial Membrane Potential
8%
Heat Shock Protein
8%
P53
8%
Mammalian Target of Rapamycin
7%
Binding Protein
7%
Antiproliferative Activity
7%
Cell Motility
7%
Vascular Endothelial Growth Factor
7%
Cell Viability
7%
Eicosanoid Receptor
7%
Dephosphorylation
7%
MUC1
6%
Protein Stability
6%
High-Mobility Group
6%
Protease-Activated Receptor 2
6%
Autophagy
6%
Complement Factor B
6%
Endoplasmic Reticulum Stress
6%
Carcinogenesis
6%
G1 Phase
6%
Upregulation
6%
Drug Resistance
6%
Wild Type
6%
Medicine and Dentistry
Cancer Cell
34%
Programmed Cell Death
33%
In Vitro
27%
Colorectal Cancer
27%
Tumor Progression
17%
Antineoplastic Activity
15%
Histone Deacetylase
15%
Tumor Angiogenesis
14%
Pancreas Cancer
13%
Histone Deacetylase Inhibitor
13%
Metastatic Carcinoma
13%
Cancer Therapy
13%
STAT3 Protein
12%
Tubulin
12%
Cell Proliferation
11%
Xenograft
11%
Mitosis Inhibition
11%
Signal Transduction
10%
Ovarian Cancer
10%
Neoplasm
9%
Cancer Growth
9%
Upregulation
9%
Anticarcinogen
9%
Angiogenesis
9%
Malignant Neoplasm
8%
Vascular Smooth Muscle Cell
8%
Phosphotransferase
7%
Histone Deacetylase 6
7%
Vorinostat
7%
Human Umbilical Vein Endothelial Cell
7%
Protein P53
7%
4 Iodo 2,5 Dimethoxyamphetamine
6%
Antimitotic Agent
6%
Sulfonyl
6%
Tissue Inhibitor of Metalloproteinase 3
6%
Amino Terminal Sequence
6%
Endothelial Cell
6%
IC50
5%
Cell Cycle Progression
5%
Phosphoinositide 3-Kinase
5%
Cell Viability
5%
HDAC1
5%
Mitogen-Activated Protein Kinase
5%
